3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>






You are here : 3-RX.com > Medical Encyclopedia > Diseases and Conditions > Drug-Induced Immune Hemolytic Anemia: Prevention & Expectations
      Category : Health Centers > Blood Disorders and Lymphatic System

Drug-Induced Immune Hemolytic Anemia

Alternate Names : Drug-Induced Hemolytic Anemia

Drug-Induced Immune Hemolytic Anemia | Symptoms & Signs | Diagnosis & Tests | Prevention & Expectations | Treatment & Monitoring

What can be done to prevent the disease?

People who have suffered from hemolytic anemia due to a particular drug should avoid that medication. However, if the reaction has not occurred in the past it is hard to predict. Often, it cannot be avoided.

What are the long-term effects of the disease?

Persons with hemolysis may develop severe shortage of red blood cells. People with underlying lung or heart disease may be at risk for further damage to the body if the blood counts remain low. For example, a person can suffer a heart attack as the result of very low blood counts

What are the risks to others?

Drug induced immune hemolysis is not contagious. It does not place other people at risk.


Previous section

 

Next section

Drug-Induced Immune Hemolytic Anemia: Diagnosis & Tests

 

Drug-Induced Immune Hemolytic Anemia: Treatment & Monitoring

Author: Adam Brochert, MD
Reviewer: H. William Kelly, PharmD
Date Reviewed: 09/24/01



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>





Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site